APCEDEN: Personalized Immunotherapy for Cancer with Dendritic Cells
APAC BIOTECH is an Indian biotechnology company that was set up with an aim of finding roots to treatment of Cancer that has fast turned into an epidemic world over by transformi--ng the promise of science and biotechnology into therapies that have the power to restore health or even save lives of cancer patients. The company has been involved in Dendritic Cell (DC) based Immunotherapy research and on the basis of the trial conducted PAN India, has been given due approvals in March 2017 by the Indian FDA (CDSCO) for Manufacturing & Marketing DC-based Immunotherapy under the brand name APCEDEN.
Currently APCEDEN is available at Medanta Mediciti Gurgaon, Apollo Hospitals, Delhi & Ruby Hall clinic, Pune. We are in the process of tying up with other major hospitals across India and very soon will be having Sir Ganga Ram Hospital, New Delhi, Max Hospital, Patparganj & Fortis Hospital, Mohali.
Whats New
📷